Edesa Biotech Inc buy Brookline Capital Management
Start price
12.10.23
/
50%
€0.39
Target price
12.10.24
€54.12
Performance (%)
0.00%
End price
13.10.24
-
Summary
This prediction is currently being closed. The BUY prediction by Brookline_Capital_Ma is currently unchanged from the start price. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Edesa Biotech Inc | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Edesa Biotech Inc diskutieren
Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at Brookline Capital Management. They now have a $57.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat
In the thread Trading Edesa Biotech Inc
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten

